Tropind Plus is a combination ophthalmic solution containing Tropicamide 0.8% and Phenylephrine 5%. This formulation is primarily used for both diagnostic and therapeutic purposes in ophthalmology. 🩺 Primary Uses of Tropind Plus 1. Pupillary Dilation (Mydriasis): The combination of Tropicamide and Phenylephrine effectively dilates the pupil, allowing eye care professionals to conduct thorough examinations of the retina, optic nerve, and other internal structures. 2. Cycloplegia: Tropicamide paralyzes the ciliary muscle, preventing accommodation (focusing), which is useful in refractive error assessments. 3. Uveitis Management: In cases of uveitis, Tropind Plus helps alleviate pain and prevents further spasms of the eye muscles. 4. Preoperative Preparation: Before surgeries like cataract extraction or retinal procedures, dilating the pupil is essential for clear visualization of the posterior segment. 5. Retinal Imaging: Facilitates procedures such as fundus photography and optical coherence tomography (OCT) by ensuring adequate pupil dilation. ⚙️ How It Works • Tropicamide is a parasympatholytic agent that inhibits the contraction of the circular muscle and paralyzes the ciliary muscle, leading to pupil dilation and cycloplegia. Phenylephrine is a sympathomimetic drug that causes contraction of the radial muscle of the iris, contributing to pupil dilation. Together, these agents produce rapid and effective dilation of the pupil, facilitating detailed eye examinations and procedures. ⚠️ Side Effects Common side effects may include: • Eye pain or stinging • Blurred vision • Sensitivity to light (photophobia) • Allergic reactions These effects are typically temporary and resolve shortly after the examination. 🧪 Safety and Precautions • Driving and Operating Machinery: Avoid activities that require clear vision, such as driving, immediately after application, as the solution can cause temporary blurred vision. • Pregnancy and Breastfeeding: Consult a healthcare provider before use during pregnancy or while breastfeeding, as safety data may be limited. • Drug Interactions: Be cautious when using Tropind Plus with certain medications, especially monoamine oxidase inhibitors (MAOIs) or tricyclic antidepressants, as interactions may occur.

Celginase 10000 Injection belongs to the class of medicines called antineoplastic (anticancer) agents used in the treatment of acute lymphoblastic leukaemia (a type of blood and bone marrow cancer). Acute lymphoblastic leukaemia (ALL) is the most common childhood cancer. It is a type of blood cancer which causes excessive production of lymphocytes (a type of white blood cells) by the bone marrow. Celginase 10000 Injection contains L Asparaginase which works by lowering asparagine levels in the body, which is necessary for the survival of cancer cells. Thus, Celginase 10000 Injection stops the cancer cells from dividing and growing. Celginase 10000 Injection will be administered by a healthcare professional; do not self-administer. Sometimes, Celginase 10000 Injection may cause common side effects such as nausea, weight loss, generalised pain or muscle pain, infections or a decrease in normal blood content. Most of these side effects of Celginase 10000 Injection do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. If you are allergic to L asparaginase or other medicines, please tell your doctor. You are recommended to avoid breastfeeding during treatment with Celginase 10000 Injection as there may be a risk to the feeding child. If you are pregnant or planning pregnancy, please inform your doctor before receiving Celginase 10000 Injection. Also, you are recommended to use effective contraceptive methods before and for at least 3 months after treatment with Celginase 10000 Injection to prevent pregnancy. Celginase 10000 Injection is given to children in doses as advised by the doctor, depending on the age. Avoid driving after receiving Celginase 10000 Injection as it may cause drowsiness or dizziness.

Luprova 11.25 mg Injection belongs to the class of 'anticancer or anti-neoplastic agents', primarily used to treat prostate cancer in men, breast cancer and endometriosis in women and precocious puberty (early puberty) in children. Prostate cancer is the prostate gland's cancer (a small gland under the bladder secretes fluid that nourishes and protects sperm) found only in men. Breast cancer is a type of cancer that develops in breast cells stimulated by a female sex hormone called oestrogen. Endometriosis is a disorder in which tissue lining the uterus grows outside the uterine cavity. Precocious puberty occurs when a child's body changes into that of an adult or experiences puberty too soon. Luprova 11.25 mg Injection contains Leuprolide that belongs to the class of gonadotropin-releasing hormone (GnRH) agonists. It is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. This process of lowering hormone levels can decrease cancer cell's growth in prostate cancer in men and shrinks endometriosis and breast cancer in women. Take Luprova 11.25 mg Injection as prescribed by your doctor. Your doctor will decide the dosage depending on your medical condition. The common side effects of Luprova 11.25 mg Injection include hot flashes, decreased sexual interest, shrinking of the testicles, breast tenderness or swelling, dizziness, headache, nausea, vomiting, diarrhoea, upset stomach and injection site pain reaction. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

Ingredient Lopinavir 200 mg+Ritonavir 50 mg Country Of Origin India Name of Manufacturer/Marketer APRAZER HEALTHCARE PVT LTD Address of Manufacturer/Marketer B 224 First Floor Phase 1 Naraina Industrial Area New Delhi 110028 India Name of Manufacturer Medicamen Organics Ltd Lopinavir 200 mg + Ritonavir 50 mg Description: This medication is a combination of two antiretroviral agents used primarily in the treatment of HIV-1 infection. Lopinavir is a protease inhibitor that blocks the HIV protease enzyme, preventing the virus from replicating inside human cells. Ritonavir, also a protease inhibitor, is used in this combination mainly to boost the effectiveness of lopinavir. It inhibits the enzyme that breaks down lopinavir in the body, increasing its levels and prolonging its activity. Uses: Treatment of HIV-1 infection in combination with other antiretroviral drugs. Helps reduce the viral load in the body and increase CD4 cell count, improving immune function. Form: Typically available as oral tablets or capsules. Each tablet contains Lopinavir 200 mg and Ritonavir 50 mg. Important Note: This medication does not cure HIV or AIDS, but it helps manage the condition and lowers the risk of complications. It should be taken under the supervision of a healthcare professional.

Decarb 200mg injection is an antineoplastic drug belonging to the class of alkylating agents, containing the active ingredient Dacarbazine. It is used to prevent and treat metastatic malignant melanoma (skin cancer), Hodgkin's disease (cancer that forms in the lymph system, part of the immune system). It is often combined with cisplatin, a cytotoxic agent, to treat certain types of cancers for the treatment of Hodgkin's lymphoma, and also combined with temozolomide for the treatment of melanoma. There may be an increased risk of certain types of skin cancer (non-melanoma skin cancer) with the use of this medicine. This drug is contraindicated in pregnant women, and women of childbearing potential should use effective contraception during and for at least 6 months after treatment with the drug. It is not known whether it is excreted in human milk, so breastfeeding should be avoided during treatment with the drug. It should also be used with caution in patients with pre-existing liver or kidney dysfunction. You should not have a live vaccine if you are having this injection. This is because it may weaken your immune system and make you more likely to catch a serious infection. Consult your doctor immediately for more advice.

Decarb 500mg injection is an antineoplastic drug belonging to the class of alkylating agents, containing the active ingredient Dacarbazine. It is used to prevent and treat metastatic malignant melanoma (skin cancer), Hodgkin's disease (cancer that forms in the lymph system, part of the immune system). It is often combined with cisplatin, a cytotoxic agent, to treat certain types of cancers for the treatment of Hodgkin's lymphoma, and also combined with temozolomide for the treatment of melanoma. There may be an increased risk of certain types of skin cancer (non-melanoma skin cancer) with the use of this medicine. This drug is contraindicated in pregnant women, and women of childbearing potential should use effective contraception during and for at least 6 months after treatment with the drug. It is not known whether it is excreted in human milk, so breastfeeding should be avoided during treatment with the drug. It should also be used with caution in patients with pre-existing liver or kidney dysfunction. You should not have a live vaccine if you are having this injection. This is because it may weaken your immune system and make you more likely to catch a serious infection. Consult your doctor immediately for more advice.

ALKACEL 5MG TABLET belongs to a class of cytotoxic drugs, also known as chemotherapeutic agents, primarily used to treat various cancer conditions such as Multiple myeloma, Polycythaemia vera, advanced cancer of the ovaries and advanced breast cancer. Cancer is a genetic change in which the body's cells divide uncontrollably and spread into surrounding tissues. ALKACEL 5MG TABLET contains Melphalan, which reduces the number of abnormal cells your body makes. Thus, it treats cancer efficiently. Use ALKACEL 5MG TABLET as directed by your doctor. It may cause common side effects, such as a drop in the number of blood cells and platelets, feeling sick (nausea), being sick (vomiting), diarrhoea, mouth ulcers, hair loss and high levels of urea in your blood (in people with kidney problems who are being treated for myeloma). Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if any of these side effects persist or worsen.

ALKACEL 2MG TABLET belongs to a class of cytotoxic drugs, also known as chemotherapeutic agents, primarily used to treat various cancer conditions such as Multiple myeloma, Polycythaemia vera, advanced cancer of the ovaries and advanced breast cancer. Cancer is a genetic change in which the body's cells divide uncontrollably and spread into surrounding tissues. ALKACEL 2MG TABLET contains Melphalan, which reduces the number of abnormal cells your body makes. Thus, it treats cancer efficiently. Use ALKACEL 2MG TABLET as directed by your doctor. It may cause common side effects, such as a drop in the number of blood cells and platelets, feeling sick (nausea), being sick (vomiting), diarrhoea, mouth ulcers, hair loss and high levels of urea in your blood (in people with kidney problems who are being treated for myeloma). Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if any of these side effects persist or worsen.

Oxa 50mg Injection belongs to the group of medications called platinum-based antineoplastic agents. It consists of the active ingredient Oxaliplatin. It is prescribed to treat stage 3 colon cancer after resectioning (surgical removal) of the primary tumor, metastatic colon and rectum cancer. It is used in combination with other anti-cancer medicines. Colorectal cancer is cancer that usually develops in the rectum and large intestine. It develops from the accumulation of various genetic mutations. Both environmental and genetic factors play a significant role in the origin of colorectal cancer. This medicine works against tumors that are resistant to cisplatin therapy. The common side effects that are likely to associate with Oxa 50mg Injection are a reduced number of blood cells, unpleasant sensation in the throat, diarrhea, nausea, vomiting, indigestion, heartburn, blood clots, blood in urine, high blood pressure, depression, insomnia, low calcium level. Inform your doctor if these side effects disturb or persist in you.